These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
444 related items for PubMed ID: 25948811
1. A population response analysis approach to assign class II HLA-epitope restrictions. Paul S, Dillon MBC, Arlehamn CSL, Huang H, Davis MM, McKinney DM, Scriba TJ, Sidney J, Peters B, Sette A. J Immunol; 2015 Jun 15; 194(12):6164-6176. PubMed ID: 25948811 [Abstract] [Full Text] [Related]
2. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy. Mitić NS, Pavlović MD, Jandrlić DR. J Immunol Methods; 2014 Apr 15; 406():83-103. PubMed ID: 24614036 [Abstract] [Full Text] [Related]
3. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis. Bordbar A, Bagheri KP, Ebrahimi S, Parvizi P. Infect Genet Evol; 2020 Jun 15; 80():104189. PubMed ID: 31931259 [Abstract] [Full Text] [Related]
4. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases. Oyarzun P, Ellis JJ, Gonzalez-Galarza FF, Jones AR, Middleton D, Boden M, Kobe B. Vaccine; 2015 Mar 03; 33(10):1267-73. PubMed ID: 25629524 [Abstract] [Full Text] [Related]
5. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes. Simon P, Omokoko TA, Breitkreuz A, Hebich L, Kreiter S, Attig S, Konur A, Britten CM, Paret C, Dhaene K, Türeci Ö, Sahin U. Cancer Immunol Res; 2014 Dec 03; 2(12):1230-44. PubMed ID: 25245536 [Abstract] [Full Text] [Related]
6. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Hattotuwagama CK, Doytchinova IA, Flower DR. Methods Mol Biol; 2007 Dec 03; 409():227-45. PubMed ID: 18450004 [Abstract] [Full Text] [Related]
9. Class II HLA-peptide binding prediction using structural principles. Mohanapriya A, Lulu S, Kayathri R, Kangueane P. Hum Immunol; 2009 Mar 03; 70(3):159-69. PubMed ID: 19187794 [Abstract] [Full Text] [Related]
11. Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method. Gutiérrez AH, Martin WD, Bailey-Kellogg C, Terry F, Moise L, De Groot AS. BMC Bioinformatics; 2015 Sep 15; 16():290. PubMed ID: 26370412 [Abstract] [Full Text] [Related]
12. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens. Mortier MC, Jongert E, Mettens P, Ruelle JL. BMC Immunol; 2015 Oct 22; 16():63. PubMed ID: 26493839 [Abstract] [Full Text] [Related]
13. Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes. Paul S, Arlehamn CSL, Schulten V, Westernberg L, Sidney J, Peters B, Sette A. BMC Immunol; 2017 Jun 21; 18(Suppl 1):20. PubMed ID: 28681704 [Abstract] [Full Text] [Related]
14. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition. Schneidman-Duhovny D, Khuri N, Dong GQ, Winter MB, Shifrut E, Friedman N, Craik CS, Pratt KP, Paz P, Aswad F, Sali A. PLoS One; 2018 Jun 21; 13(11):e0206654. PubMed ID: 30399156 [Abstract] [Full Text] [Related]
15. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. Paul S, Lindestam Arlehamn CS, Scriba TJ, Dillon MB, Oseroff C, Hinz D, McKinney DM, Carrasco Pro S, Sidney J, Peters B, Sette A. J Immunol Methods; 2015 Jul 21; 422():28-34. PubMed ID: 25862607 [Abstract] [Full Text] [Related]
16. Extensive HLA class I allele promiscuity among viral CTL epitopes. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, Walker BD, Sette A, Heckerman D, Korber BT, Brander C. Eur J Immunol; 2007 Sep 21; 37(9):2419-33. PubMed ID: 17705138 [Abstract] [Full Text] [Related]
17. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity. Hoof I, Pérez CL, Buggert M, Gustafsson RK, Nielsen M, Lund O, Karlsson AC. J Immunol; 2010 May 01; 184(9):5383-91. PubMed ID: 20363973 [Abstract] [Full Text] [Related]
18. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis. Musson JA, Reynolds CJ, Rinchai D, Nithichanon A, Khaenam P, Favry E, Spink N, Chu KK, De Soyza A, Bancroft GJ, Lertmemongkolchai G, Maillere B, Boyton RJ, Altmann DM, Robinson JH. J Immunol; 2014 Dec 15; 193(12):6041-9. PubMed ID: 25392525 [Abstract] [Full Text] [Related]
19. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs. Uemura Y, Senju S, Maenaka K, Iwai LK, Fujii S, Tabata H, Tsukamoto H, Hirata S, Chen YZ, Nishimura Y. J Immunol; 2003 Jan 15; 170(2):947-60. PubMed ID: 12517961 [Abstract] [Full Text] [Related]
20. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Paul S, Karosiene E, Dhanda SK, Jurtz V, Edwards L, Nielsen M, Sette A, Peters B. Front Immunol; 2018 Jan 15; 9():1795. PubMed ID: 30127785 [Abstract] [Full Text] [Related] Page: [Next] [New Search]